WELL Health Technologies Corp. entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc. on July 19, 2023. The acquisition brings more than 130.
WELL Health Technologies Corp. entered into an agreement to acquire Significant Portion of Clinical Assets of MCI Medical clinics Inc. on July 19, 2023. The acquisition brings more than 130.
Dr. Feng Ren, Chief Scientific Officer (CSO) and head of global research and development is named co-CEO of Insilico Medicine Highlights: Insilico Medicine is a global, end-to-end, fully-integrated AI-powered biotechnology company with three business models: AI platform, collaboration, and internal pipeline. It utilizes AI and a fully distributed, highly parallel discovery model to rapidly develop its own drugs. Since 2021, the company has nominated 8 preclinical candidates and reached Phase I clinical trials with an AI-discovered and AI-designed molecule. It is also developing a set of AI platforms for target discovery, multi-parameter optimization, generative chemistry, and prediction of clinical trials. In the pharmaceutical industry, the internal pipeline, and especially, clinical assets, are much more important and expensive than computational platforms and other enabling technologies. Historically, companies in computationally-augmented discovery, reduced or completely eliminated
Investegate |Oxurion NV Announcements | Oxurion NV: Oxurion NV Business & Financial Update – H1 2021 investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.